Specifically, a 3-staging system, validated by unbiased statistical classification, may be more sensitive to changes in underlying Aβ42, tau, and concomitant pathologies not detected by dichotomous approaches, allowing clinicians to better predict relevant disease processes underlying cognitive impairment. Here, MAPT is linked to Cognitive impairment.